IRWD
Ironwood Pharmaceuticals IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$564.18M
P/E Ratio
23.07
EPS
$0.15
Beta
0.17
52W High
$5.78
52W Low
$0.53
50-Day MA
$3.96
200-Day MA
$2.50
Dividend Yield
—
Profit Margin
8.11%
Forward P/E
12.33
PEG Ratio
-0.26
About Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. The company is headquartered in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | $296.15M |
| Gross Profit (TTM) | $201.01M |
| EBITDA | $120.64M |
| Operating Margin | 13.70% |
| Return on Equity | -575.00% |
| Return on Assets | 19.90% |
| Revenue/Share (TTM) | $1.83 |
| Book Value | $-1.61 |
| Price-to-Book | 2.59 |
| Price-to-Sales (TTM) | 1.91 |
| EV/Revenue | 3.235 |
| EV/EBITDA | 9.15 |
| Quarterly Earnings Growth (YoY) | 1047.00% |
| Quarterly Revenue Growth (YoY) | -47.30% |
| Shares Outstanding | $163.06M |
| Float | $125.58M |
| % Insiders | 3.05% |
| % Institutions | 91.67% |
Analyst Ratings
Consensus ($6.10 target)
1
Strong Buy1
Buy2
HoldData last updated: 4/8/2026